Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05028751 |
|---|---|
| Brief Title: | A Study to Evaluate Lanraplenib (LANRA) in Combination With Gilteritinib in Participants With FLT3-mutated Relapsed or Refractory Acute Myeloid Leukemia (AML) |
| First Submitted : | August 25, 2021 |
| First Submitted that Met QC Criteria : | August 25, 2021 |
| First Posted : | August 31, 2021 |
| Last Update Submitted that Met QC Criteria : | December 16, 2022 |
| Last Update Posted : | December 19, 2022 |